Rocket Pharmaceuticals Inc
RCKT - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$267.85M
Close$
$0.47
80.5% downside
Current Fair Value
80.5% downsideOvervalued by 80.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $267.85 Million |
|---|---|
| Enterprise Value | $68.14 Million |
| Earnings per Share | $-2.01 |
| Beta | 0.5 |
| Outstanding Shares | 112,844,880 |
Return
| Return on Equity | -4.68% |
|---|---|
| Return on Assets | -4.08% |
| Return on Invested Capital | -1.96% |
Valuation & Multiples
| P/E Ratio | -15.25 |
|---|---|
| PEG | 5.47 |
| Price to Sales | - |
| Price to Book Ratio | 0.81 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -8.87 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.36 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 5, 2026
EPS Estimate
$-0.40
Consensus analyst estimateRevenue Estimate
$200,000
Consensus analyst estimateNext Earnings Call
Expected Date
March 1, 2027
EPS Estimate
$-0.40
Consensus analyst estimateRevenue Estimate
$687,100
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 7.47% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.13%▼ 88.89% |
|---|---|
| Total Invested | $394,673▼ 99.89% |
| Investors Holding | 12▼ 173.00% |
About Rocket Pharmaceuticals Inc
151 employees
CEO: Gaurav Shah
